Acibadem Healthcare Group
Şule Ketenci Ertaş
M.D.

Şule Ketenci Ertaş

Medical Units and Clinical Services
  • Rheumatology

M.D. Şule Ketenci Ertaş is a rheumatologist trained at Erciyes University Faculty of Medicine, where she completed her specialty in Rheumatology in 2019. Since 2021 she has been practicing with Acıbadem Health Group, providing comprehensive care for patients with autoimmune and musculoskeletal conditions. M.D. Ertaş is an active member of the Turkish Rheumatology Association and stays engaged with current advances in rheumatology to deliver evidence-based treatment and personalized patient care.

Education

  • 2019 Erciyes University Faculty of Medicine Rheumatology
  • 2014 Erciyes University Faculty of Medicine Internal Medicine
  • 2007 Hacettepe University Faculty of Medicine

Experience

  • 2021 Acibadem Health Group
  • 2020 – 2021 Kayseri City Hospital , Rheumatology Specialist Dr.
  • 2019 – 2020 Tokat State Hospital, Rheumatology Specialist Dr.

Memberships

  • Turkish Rheumatology Association

Publications

  • A case of fulminant demyelinating disease associated with golimumab treatment
    (2020) Yetkin, M. F., Kendirci, M., Ismailogullari, S., Gültekin, M., Baydemir, R., Sarilar, A. Ç., Ertas ŞK,. & Mirza, M.
  • Fatigue Is Common and Predicted by Female Gender and Sleep Disturbance in Patients with Chronic Spontaneous Urticaria
    The Journal of Allergy and Clinical Immunology: In Practice, 2020, 9.1: 469-476. EROL, Kemal; ERTAŞ, Şule Ketenci; ERTAŞ, Ragıp
  • Antinuclear antibodies are common and linked to poor response to omalizumab treatment in patients with CSU
    Allergy, 75(2), 468-470. (2020) Ertaş, R., Hawro, T., Altrichter, S., Özyurt, K., Erol, K., Ketenci Ertaş, Ş., & Maurer, M.
  • Is increased intracranial pressure a reason for headache in COVID-19 patients?
    Evaluation with optic nerve sheath diameter Zuhal Ozer Simsek, Seda Guzeldag, Sule Ketenci Ertas, Yasemin Dincaslan
  • Successful treatment of tubulointerstitial nephritis in immunoglobulin G4-related disease with rituximab: A case report
    World journal of clinical cases, 7(16), 2309. (2019) Eroglu, E., Sipahioglu, M. H., Senel, S., Ertas, S. K., Savas, S., Ozturk, F., … & Oymak, O.
  • Case Report: Behçets disease accompanied with vitiligo
    F1000Research, 6. (2017) Ertas, R., Ozyurt, K., Avci, A., Ertas, S. K., & Atasoy, M.
  • Case Report: Behçets disease accompanied with vitiligo
    Case Report: Behçet?s disease accompanied with vitiligo (2017) Ragıp, E., Kemal, Ö., Atıl, A., Sule, K. E., & Mustafa, A.
  • Immunohistochemical investigation of P16, P53 and Ki-67’s prognostic values in diffuse large B-Cell lymphomas
    Bratislavske lekarske listy, 118(10), 602-608. (2017) Baran, M., Canoz, O., Altuntas, H., Sivgin, S., Cetin, M.Yay, A., & Ketenci, S.
  • Androgenetic alopecia as an indicator of metabolic syndrome and cardiovascular risk
    Blood pressure, 25(3), 141-148. (2016) Ertas, R., Orscelik, O., Kartal, D., Dogan, A., Ertas, S. K., Aydogdu, E. G., … & Borlu, M
  • Mutations in IDH1, IDH2, PON1 genes in patients with diffuse large b-cell lymphoma
    Current Opinion in Biotechnology, (24), S98. 82013) Akalin, H., Ertas, S. K., Akbarova, Y., Ozkul, Y., & Unal, A.


Same Branch Doctors: Rheumatology

×
Logo

29 hospitals and 15 medical centers in 5 countries.

About Us
Hospitals
Treatments
Doctors
Medical Technologies
Check Up Packages
Appointment
Blog
Contact
Contact Us
Promotional
About Us

At ACIBADEM Healthcare Group, we are committed to healthcare excellence and providing world-class healthcare services to our patients. As a leader in international healthcare, we strive to deliver the highest quality of care and meet the needs of our diverse patient population.

Read More...
Appointment FormLive Support
Manage your privacy

We use technologies like cookies to store and/or access device information. We do this to improve browsing experience and to show (non-) personalized ads. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional
Always active
Preferences
Statistics